EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oxidative stress and genetic susceptibility to cross‐reactive and selective NSAID hypersensitivity

Jesús Miguel García-Menaya iD, Javier Gómez-Tabales iD, Sofía Ladera-Navarro iD, Manuel Martí iD, Natalia Blanca-López iD, José Augusto García-Agúndez iD, Elena García-Martín iD, Pedro Ayuso iD

British Journal of Pharmacology · 15.11.2026

DOI: 10.1111/bph.70736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 15.11.2026. Verfasst von Jesús Miguel García-Menaya und 7 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, Cáceres, Spain. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Junta de Extremadura, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Nonsteroidal anti‐inflammatory drugs (NSAIDs) are a leading cause of drug hypersensitivity reactions (HRs), but genetic determinants of individual susceptibility remain unclear. Here, we identified genetic variants in redox‐ and immune‐related pathways associated with cross‐reactive NSAID hypersensitivity (CR‐NSAID) and single‐NSAID–induced urticaria/angioedema/anaphylaxis (SNIUAA) and to characterize their functional relevance. Experimental Approach A multicentre prospective case–control study was conducted in Spanish individuals of European ancestry, including patients with confirmed NSAID hypersensitivity and NSAID‐tolerant individuals. Single nucleotide variants (SNVs) in redox‐ and immune‐related genes were genotyped using a two‐stage discovery and independent replication design. SNVs showing significant associations were functionally evaluated by measuring serum glutathione S‐transferase (GST), superoxide dismutase (SOD) and aldo‐keto reductase (AKR) activities according to genotype. Key Results GSTM5 rs11101989 and GSTZ1 haplotype (rs1046428, rs7975, rs7972) associated with increased susceptibility to CR‐NSAID. Functional analyses demonstrated that carriers of the GSTM5 rs11101989 CC genotype had significantly reduced total serum GST activity. In SNIUAA, SOD1 variants (rs2070424 and rs2833483) associated with increased susceptibility and reduced serum SOD activity. Additionally, AKR1C3 rs34186955 increased susceptibility, whereas AKR1C3 rs12529 and IL4R rs1805016 associated with decreased susceptibility. Integration of genetic and functional data supported involvement of redox‐related pathways in distinct NSAID hypersensitivity phenotypes and identified GSTM5 and SOD1 variants as candidate genetic susceptibility markers. Conclusions and Implications Genetic variability in redox‐related and immune‐regulatory pathways contributed to susceptibility to cross‐reactive and selective NSAID hypersensitivity. These findings support further validation of biomarker‐based strategies for personalized risk assessment and safer NSAID prescribing. Further validation in independent populations is required.

Schlagwörter

Stichwörter der Autor:innen

cross‐reactive intolerancedrug hypersensitivity reactionsnonsteroidal anti‐inflammatory drugsredoxsingle nucleotide variantssingle‐NSAID–induced urticaria/angioedema/anaphylaxis

Autor:innen und Institutionen

  • University Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, Cáceres, Spain.
  • Allergy Service, Badajoz University Hospital, Badajoz, Spain.
  • Allergy Service, Infanta Leonor University Hospital, Madrid, Spain.

ORCID-Profile: Jesús Miguel García-Menaya, Javier Gómez-Tabales, Sofía Ladera-Navarro, Manuel Martí, Natalia Blanca-López, José Augusto García-Agúndez, Elena García-Martín, Pedro Ayuso

Förderung

  • Instituto de Salud Carlos III
  • Junta de Extremadura
  • European Union
  • European Commission

Zitieren

APA

García-Menaya, J. M., Gómez-Tabales, J., Ladera-Navarro, S., Martí, M., Blanca-López, N., García-Agúndez, J. A., García-Martín, E., & Ayuso, P. (2026). Oxidative stress and genetic susceptibility to cross‐reactive and selective NSAID hypersensitivity. British Journal of Pharmacology. https://doi.org/10.1111/bph.70736

Vancouver

García-Menaya JM, Gómez-Tabales J, Ladera-Navarro S, Martí M, Blanca-López N, García-Agúndez JA, et al. Oxidative stress and genetic susceptibility to cross‐reactive and selective NSAID hypersensitivity. British Journal of Pharmacology. 2026. doi:10.1111/bph.70736

BibTeX
@article{GarcaMenaya2026,
  author = {García-Menaya, Jesús Miguel and Gómez-Tabales, Javier and Ladera-Navarro, Sofía and Martí, Manuel and Blanca-López, Natalia and García-Agúndez, José Augusto and García-Martín, Elena and Ayuso, Pedro},
  title = {Oxidative stress and genetic susceptibility to cross‐reactive and selective NSAID hypersensitivity},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70736}
}
Kostenlos starten →